Monica Mita
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 1%
Papers in
- Oncology 121
- Cancer Treatment and Pharmacology 40
- HER2/EGFR in Cancer Research 18
- Cancer Immunotherapy and Biomarkers 15
- Lung Cancer Research Studies 15
-
- PI3K/AKT/mTOR signaling in cancer 33
- Co-authors
- Alain C. Mita (103 shared papers)Francis J. Giles (11 shared papers)Steffan T. Nawrocki (8 shared papers)Eric K. Rowinsky (34 shared papers)Anthony W. Tolcher (25 shared papers)Kamalesh K. Sankhala (18 shared papers)Devalingam Mahalingam (15 shared papers)Amita Patnaik (11 shared papers)
- Journals
- Journal of Clinical Oncology (76 papers)Cancer Research (21 papers)Clinical Cancer Research (19 papers)Molecular Cancer Therapeutics (18 papers)Targeted Oncology (13 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Monica Mita
233 papers receiving 8.1k citations
Monica Mita's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 3.0k
- Cancer Research 973
- Molecular Biology 4.1k
- Pulmonary and Respiratory Medicine 1.5k
- Immunology 736
Countries citing papers authored by Monica Mita
This map shows the geographic impact of Monica Mita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Mita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Mita more than expected).
Fields of papers citing papers by Monica Mita
This network shows the impact of papers produced by Monica Mita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Mita. The network helps show where Monica Mita may publish in the future.
Co-authors
The 25 scholars most cited alongside Monica Mita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics Hit paper breakdown → | 2008 | 639 |
| 2 | 2009 | 432 | |
| 3 | Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 324 |
| 4 | 2007 | 254 | |
| 5 | 2008 | 247 | |
| 6 | 2014 | 245 | |
| 7 | 2000 | 243 | |
| 8 | 2008 | 228 | |
| 9 | 2016 | 220 | |
| 10 | 2011 | 197 | |
| 11 | 2009 | 188 | |
| 12 | 2003 | 140 | |
| 13 | 2013 | 124 | |
| 14 | 2009 | 121 | |
| 15 | 2013 | 120 | |
| 16 | 2009 | 120 | |
| 17 | 2012 | 115 | |
| 18 | 2003 | 115 | |
| 19 | 2018 | 112 | |
| 20 | 2019 | 112 |
About Monica Mita
Monica Mita is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 238 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (40 papers), PI3K/AKT/mTOR signaling in cancer (33 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Advanced Breast Cancer Therapies (21 papers), Lung Cancer Treatments and Mutations (19 papers), HER2/EGFR in Cancer Research (18 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Lung Cancer Research Studies (15 papers). The work is most often cited by research in Oncology (3.0k citations), Cancer Research (973 citations), Molecular Biology (4.1k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Immunology (736 citations). Monica Mita has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Alain C. Mita, Francis J. Giles, Steffan T. Nawrocki, Eric K. Rowinsky, Anthony W. Tolcher, Kamalesh K. Sankhala, Devalingam Mahalingam, Amita Patnaik, Esha Sachdev and Chris H. Takimoto. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Molecular Cancer Therapeutics and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.